<DOC>
	<DOC>NCT00597649</DOC>
	<brief_summary>This study is to evaluate the long-term efficacy and safety of two dosages of bicifadine SR (600 mg/day and 1200 mg/day) for up to 52 weeks in reducing chronic peripheral neuropathy pain due to diabetes in adult outpatients.</brief_summary>
	<brief_title>A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Male or female 18 years or older Diagnosis of type 1 or type 2 noninsulin dependent diabetes mellitus Chronic bilateral pain due to diabetic neuropathy, pain for at least six months. Primary pain is located in the feet. Subject participated in and completed the XTL 07001 clinical trial. Contact site for additional information. Symptoms of other painful conditions Presence of amputations other than toes Clinically significant psychiatric or other neuropsychological disorder Use of certain medications Clinically important other diseases Pregnancy History of alcohol or narcotic abuse within two years. Contact site for additional information.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>